Merck Cuts Pharma Revenue Guidance By $1.7bn Due To Pandemic

 
• By Joseph Haas
Quarterly resluts on typewriter close up
Merck enjoyed a strong first quarter but expects pandemic-related downturn in the second and third quarters

More from Earnings

More from Business